Your search returned 2 results.

Results
	1.	A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer. [electronic resource] by Sehgal, Rajesh Lembersky, Barry C Rajasenan, Kiran K Crandall, Theodore L Balaban, Edward P Pinkerton, Richard A Kane, Patrick Schmotzer, Amy Zeh, Herbert Potter, Douglas M Ramanathan, Ramesh K Producer: 20111212 In: Clinical colorectal cancer vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer. [electronic resource] by Carneiro, Benedito A Ramanathan, Ramesh K Fakih, Marwan G Krishnamurthi, Smitha S Lembersky, Barry C Stoller, Ronald G Lancaster, Stewart L Pinkerton, Richard A Crandall, Theodore L Schmotzer, Amy R Potter, Douglas M Bahary, Nathan Producer: 20120605 In: Clinical colorectal cancer vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search